- Home
- FDMT vs KRRO Comparison
FDMT vs KRRO Comparison
Compare FDMT & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- KRRO
- Stock Information
- Founded
- FDMT 2013
- KRRO 2014
- Country
- FDMT United States
- KRRO United States
- Employees
- FDMT N/A
- KRRO N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- FDMT Health Care
- KRRO Health Care
- Exchange
- FDMT Nasdaq
- KRRO Nasdaq
- Market Cap
- FDMT 391.8M
- KRRO 358.3M
- IPO Year
- FDMT 2020
- KRRO 2019
- Fundamental
- Price
- FDMT $9.97
- KRRO $45.78
- Analyst Decision
- FDMT Strong Buy
- KRRO Strong Buy
- Analyst Count
- FDMT 8
- KRRO 7
- Target Price
- FDMT $30.63
- KRRO $96.71
- AVG Volume (30 Days)
- FDMT 771.6K
- KRRO 263.2K
- Earning Date
- FDMT 11-12-2025
- KRRO 11-11-2025
- Dividend Yield
- FDMT N/A
- KRRO N/A
- EPS Growth
- FDMT N/A
- KRRO N/A
- EPS
- FDMT N/A
- KRRO N/A
- Revenue
- FDMT $33,000.00
- KRRO $6,281,000.00
- Revenue This Year
- FDMT $9,656.76
- KRRO $116.91
- Revenue Next Year
- FDMT N/A
- KRRO N/A
- P/E Ratio
- FDMT N/A
- KRRO N/A
- Revenue Growth
- FDMT N/A
- KRRO N/A
- 52 Week Low
- FDMT $2.24
- KRRO $10.29
- 52 Week High
- FDMT $10.03
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- FDMT 69.13
- KRRO 61.19
- Support Level
- FDMT $8.50
- KRRO $40.70
- Resistance Level
- FDMT $10.03
- KRRO $47.55
- Average True Range (ATR)
- FDMT 0.64
- KRRO 4.98
- MACD
- FDMT 0.07
- KRRO -0.52
- Stochastic Oscillator
- FDMT 86.96
- KRRO 64.04
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.